It has been demonstrated that curcumin and its analogues increase the expression of FOXO3a in A549 and H460 human lung cancer cells through enhancement of ROS production, subsequently elevating the expression of FOXO3a target genes including p21, p27 and Bim while decreasing the level of cyclin D1. The gene discussed is CCND1; the disease is lung carcinoma.